Pharmacokinetics and Tissue Distribution of Pilocarpine After Application to Eyelid Skin of Rats

Closed

Gerard Lee See, A. Sagesaka, Hiroaki Todo, Konstanty Wierzba, K. Sugibayashi

2019 Journal of Pharmaceutical Sciences Vol. 108 Issue 9 Article Cited by 12 Quartile

Abstract

Extending the delivery of drugs into the eyes while reducing systemic bioavailability is of utmost importance in the management of chronic ocular diseases. Topical application onto the lower eyelid skin, as an alternative to eye drops, is seen to be a valuable strategy in the treatment of chronic eye diseases. To elucidate the critical value of delivering drugs in solution onto the eyeball through the eyelid skin, pharmacokinetic studies of pilocarpine were conducted, and the results were verified using a direct pharmacodynamic study in rats. The mean residence time of pilocarpine after topical eyelid application to the eyelid skin, conjunctiva, eyeball, and plasma were 14.9, 8.50, 6.29, and 8.11 h, respectively. Conjunctiva and eyeball concentrations of pilocarpine at 8 h were 80-fold and 8-fold higher after topical eyelid application, respectively, than those for eye drops. Pupillary constriction was sustained over 8 h after topical eyelid application. Topical eyelid skin application exhibited a localized drug absorption and specific drug accumulation in the ocular tissues. Hence, it is rational to prepare topical formulations directed onto the eyelid skin, which is suitable for drugs required for long-term treatment. © 2019 American Pharmacists Association®

Affiliations

Graduate School of Pharmaceutical Sciences, Josai University, Saitama, Japan; Department of Pharmacy, School of Health Care Professions, University of San Carlos, Cebu, Philippines; Faculty of Pharmacy and Pharmaceutical Sciences, Josai University, Saitama, Japan